Candida biofilms and their role in infection

Trends in Microbiology

Volumn 11, Issue 1, 2003, Pages 30-36

  Douglas, L Julia ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; DRUG SENSITIVITY; EUKARYOTE; FUNGUS HYPHAE; GENE EXPRESSION; GROWTH RATE; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; IMPLANT; IN VITRO STUDY; INDWELLING CATHETER; MODEL; MULTIDRUG RESISTANCE; NONHUMAN; NUTRIENT LIMITATION; PRIORITY JOURNAL; PROKARYOTE; REVIEW; ULTRASTRUCTURE; YEAST;

BIOFILMS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MICROBIAL; MODELS, BIOLOGICAL; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; EUKARYOTA; FUNGI; PROKARYOTA;

EID: 0037230342     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(02)00002-1     Document Type: Review

References (55)

1. Costerton J.W., et al. Microbial biofilms. Annu. Rev. Microbiol. 49:1995;711-745.
2. O'Toole G., et al. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:2000;49-79.
3. Mah T.-F.C., O'Toole G.A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:2001;34-39.
4. Potera C. Forging a link between biofilms and disease. Science. 283:1999;1837-1838.
5. Donlan R.M. Biofilms and device-associated infections. Emerg. Infect. Dis. 7:2001;277-281.
6. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:2002;167-193.
7. Costerton J.W., et al. Bacterial biofilms: a common cause of persistent infections. Science. 284:1999;1318-1322.
8. Jenkinson H.F., Douglas L.J. Interactions between Candida species and bacteria in mixed infections. Brogden K.A., Guthmiller J.M. Polymicrobial Diseases. 2002;357-373 ASM Press.
9. Lappin-Scott, H.M., Costerton, J.W., eds, (1995) Microbial Biofilms, Cambridge University Press.
10. Allison, D.G. et al., eds, (2000) Community Structure and Co-operation in Biofilms, Cambridge University Press.
11. Odds F.C. Candida and Candidosis. 1988;Bailliere Tindall.
12. Calderone R.A. Introduction and historical perspectives. Calderone R.A. Candida and Candidiasis. 2002;3-13 ASM Press.
13. Crump J.A., Collignon P.J. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 19:2000;1-8.
14. Maki D.G., Tambyah P.A. Engineering out the risk of infection with urinary catheters. Emerg. Infect. Dis. 7:2001;1-6.
15. Adair C.G., et al. Implications of endotracheal tube biofilm ventilator-associated pneumonia. Intensive Care Med. 25:1999;1072-1076.
16. Goldmann D.A., Pier G.B. Pathogenesis of infections related to intravascular catheterization. Clin. Microbiol. Rev. 6:1993;176-192.
17. Sherertz, R.J. (2000) Pathogenesis of vascular catheter infection. In Infections Associated with Indwelling Medical Devices, 3rd edn, (Waldvogel, F.A., Bisno, A.L. eds), pp. 111-125, ASM Press.
18. Kullberg B.J., Filler S.G. Candidemia. Calderone R.A. Candida and Candidiasis. 2002;327-340 ASM Press.
19. Budtz-Jorgensen E. Candida-associated denture stomatitis and angular cheilitis. Samaranayake L.P., MacFarlane T.W. Oral Candidosis. 1990;156-183.
20. Van der Mei H.C., et al. Effect of probiotic bacteria on prevalence of yeasts in oropharyngeal biofilms on silicone rubber voice prostheses in vitro. J. Med. Microbiol. 49:2000;713-718.
21. Baillie G.S., Douglas L.J. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 310:1999;644-656.
22. Hawser S.P., Douglas L.J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:1994;915-921.
23. Hawser S.P., Douglas L.J. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39:1995;2128-2131.
24. Nikawa H., et al. The role of saliva and serum in Candida albicans biofilm formation on denture acrylic surfaces. Microb. Ecol. Health Dis. 9:1996;35-48.
25. Chandra J., et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:2001;903-908.
26. Ramage G., et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2001;2475-2479.
27. Hawser S.P., et al. Production of extracellular matrix by Candida albicans biofilms. J. Med. Microbiol. 47:1998;253-256.
28. Baillie G.S., Douglas L.J. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob. Agents Chemother. 42:1998;2146-2149.
29. Baillie G.S., Douglas L.J. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 48:1999;671-679.
30. Baillie G.S., Douglas L.J. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother. 42:1998;1900-1905.
31. Kuhn D.M., et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immun. 70:2002;878-888.
32. Shin J.H., et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J. Clin. Microbiol. 40:2002;1244-1248.
33. Lewis R.E., et al. Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob. Agents Chemother. 46:2002;1153-1155.
34. Ramage G., et al. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214:2002;95-100.
35. Ramage G., et al. Biofilm formation by Candida dubliniensis. J. Clin. Microbiol. 39:2001;3234-3240.
36. Ramage G., et al. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:2001;163-170.
37. Chandra J., et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:2001;5385-5394.
38. Suci P.A., et al. Integration of Raman microscopy, differential interference contrast microscopy, and attenuated total reflection Fourier transform infrared spectroscopy to investigate chlorhexidine spatial and temporal distribution in Candida albicans biofilms. J. Microbiol. Methods. 46:2001;193-208.
39. Sutherland I.W. The biofilm matrix - an immobilised but dynamic microbial environment. Trends Microbiol. 9:2001;222-227.
40. Baillie G.S., Douglas L.J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46:2000;397-403.
41. Lewis R.E., et al. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob. Agents Chemother. 46:2002;3499-3505.
42. Kuhn D.M., et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:2002;1773-1780.
43. Bachmann S.P., et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:2002;3591-3596.
44. Ramage G., et al. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:2002;3634-3636.
45. Stickler D.J. Chemical and physical methods of biofilm control. Wimpenny J., et al. Biofilms: Community Interactions and Control. 1997;215-225 BioLine.
46. Lewis K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:2001;999-1007.
47. Maira-Litran T., et al. Expression of the multiple antibiotic resistance operon (mar ) during growth of Escherichia coli as a biofilm. J. Appl. Microbiol. 88:2000;243-247.
48. Brooun A., et al. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:2000;640-646.
49. Ramage G., et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49:2002;973-980.
50. Adam B., et al. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J. Med. Microbiol. 51:2002;344-349.
51. Skillman L.C., et al. The role of exopolysaccharides in dual species biofilm development. J. Appl. Microbiol. 85:(Suppl.):1999;13S-18S.
52. Hogan D.A., Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science. 296:2002;2229-2232.
53. Swift S., et al. Quorum sensing: a population-density component in the determination of bacterial phenotype. Trends Biochem. Sci. 21:1996;214-219.
54. Davies D.G., et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 280:1998;295-298.
55. Hornby J.M., et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2001;2982-2992.